Closed Loop Auditory Stimulus in Sleep and epilepsY (CLASSY)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cardiff, United Kingdom, CF14 4XW
- Cardiff and Vale UHW, Neurology department, ward C4, video-EEG monitoring unit
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participant is willing and able to give informed consent
- Participant diagnosed with temporal lobe epilepsy
- Will have had fewer than three generalized tonic clonic seizures per month in the last three months
- Will be taking 3 or fewer anti-seizure medications.
- Will have access to a computer or cellphone with an internet connection
Exclusion Criteria:
- Abnormal hearing that cannot be corrected to normal overnight.
- Abnormal vision that cannot be corrected to normal during the day.
- Unwilling to abstain from caffeine, alcohol, daytime naps and extreme physical exercise in the 12 hours prior to the study.
- Cannot read English
- Engaged in night work in the previous 2 months
- Any history of seizures triggered by music or sounds
- Travelled across more than 2 time zones in the last 2 months
- Prescribed/taking sleeping tablets other than clobazam
- Cannabis use >4 joints/day.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Stim First
Participants slept for one night while auditory sounds were played at specific points during slow wave sleep.
At least one week later, an identical procedure occured with no acoustic sounds.
|
50ms of low volume pink noise delivered during slow wave sleep
|
|
Sham Comparator: Sham First
Participants slept for one night while no acoustic sounds were played.
At least one week later, an identical procedure occured while acoustic sounds were played at specific points during slow wave sleep.
|
50ms of low volume pink noise delivered during slow wave sleep
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in EEG waveform amplitude
Time Frame: 5 seconds after stimulus
|
Does the acoustic sound delivery alter EEG waveform amplitude of slow wave sleep
|
5 seconds after stimulus
|
|
Change in Serial Reaction Time Task memory test
Time Frame: Baseline and following day
|
Does the delivery of acoustic sounds alter post-sleep preformance on the above task
|
Baseline and following day
|
|
Change in Paired Associates Learning memory test
Time Frame: Baseline and following day
|
Does the delivery of acoustic sounds alter post-sleep preformance on the above task
|
Baseline and following day
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Khalid Hamandi, MRCP/Phd, University Hospital of Wales/Cardiff University
- Principal Investigator: Jennifer Roebber, PhD, University Hospital of Wales/Cardiff University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 7796
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.